[1] KONES R.Primary prevention of coronary heart disease:integration of new data,evolving views,revised goals,and role of rosuvastatin in management.A comprehensive survey[J].Drug Des Devel Ther,2011,5:325.
[2] SIADAT ZD,KIANI K,SADEGHI M,et al.Association of vitamin D deficiency and coronary artery disease with cardiovascular risk factors[J].J Res Med Sci,2012,17(11):1052.
[3] MAHALLE N,KULKARNI MV,GARG MK,et al.Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease[J].J Cardiol,2013,61(4):289.
[4] 户富栋,王祥,朱争凤,等.血电解质和白蛋白浓度与冠状动脉病变严重性的关系[J].临床心血管病杂志,2011,27(2):126.
[5] 徐玮,宣玲,卢冬雨,等.心肌缺血总负荷值、心率变异性及校正Q-T离散度与冠状动脉病变程度的相关性[J].蚌埠医学院学报,2014,39(2):163.
[6] GAO Y,CHEN G,TIAN H,et al.Prevalence of hypertension in china:a cross-sectional study[J].PLoS One,2013,8(6):e65938.
[7] DANAEI G,FINUCANE MM,LU Y,et al.National,regional,and global trends in fasting plasma glucose and diabetes prevalence since 1980:systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants[J].Lancet,2011,378(9785):31.
[8] XU Y,WANG L,HE J,et al.Prevalence and control of diabetes in chinese adults[J].JAMA,2013,310(9):948.
[9] JOFFRES M,FALASCHETTI E,GILLESPIE C,et al.Hypertension prevalence,awareness,treatment and control in national surveys from England,the USA and Canada,and correlation with stroke and ischaemic heart disease mortality:a cross-sectional study[J].BMJ Open,2013,3(8):e003423.
[10] FARKOUH ME,BODEN WE,BITTNER V,et al.Risk factor control for coronary artery disease secondary prevention in large randomized trials[J].J Am Coll Cardiol,2013,61(15):1607.
[11] YANG ZJ,LIU J,GE JP,et al.Prevalence of cardiovascular disease risk factor in the Chinese population:the 2007-2008 China National Diabetes and Metabolic Disorders Study[J].Eur Heart J,2012,33(2):213.
[12] HEMANN BA,BIMSON WF,TAYLOR AJ.The Framingham Risk Score:an appraisal of its benefits and limitations[J].Am Heart Hosp J,2007,5(2):91.